Sat, February 22, 2025
Fri, February 21, 2025
Thu, February 20, 2025

Shortage of Novo's Wegovy and Ozempic is resolved, FDA website shows

  Copy link into your clipboard //health-fitness.news-articles.net/content/2025/ .. y-and-ozempic-is-resolved-fda-website-shows.html
  Print publication without navigation Published in Health and Fitness on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, the U.S. Food and Drug Administration's website showed on Friday. The resol
The shortage of Novo Nordisk's weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved according to the U.S. Food and Drug Administration's (FDA) website. Previously, there were supply issues due to high demand, but the FDA now lists all dose strengths of Wegovy and Ozempic as available. This resolution comes after Novo Nordisk had to limit the supply of certain doses to ensure continuity for existing patients. The drugs, which use the active ingredient semaglutide, have seen increased demand due to their effectiveness in managing type 2 diabetes and aiding weight loss. The availability update was reflected on the FDA's website, signaling an end to the intermittent shortages that had affected patients' access to these medications.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/other/shortage-of-novo-s-wegovy-and-ozempic-is-resolved-fda-website-shows/ar-AA1zwwcE ]